Is this the cheapest Bio Tech stock, on the ASX or even the...

Is this the cheapest Bio Tech stock, on the ASX or even the world,concidering, where this company has progressed to and what is just around the corner?

Let me get this correct, and open for discussion,

PharmAust has at the end of December 2017, $2,945,646.00 in the bank.

We are at the end of the BRI reformulation, announcement pending, canine trials, one would sincerely hope, going to run concurrently worldwide?

Two world renown veterinary oncologists, along with the ex president of Novatis Animal Products, some of the finest in their respective fields, that along with Dr Hopkins, Dr Mollard, Dr Best and Dr Aston and directors, and blow me down, PharmAusts share price is 5.5 cents!!!

Go figure....


PHARMAUST LIMITED STATEMENT OF CASH FLOWS For the half-year ended 31 December 2017 Consolidated 31 December 31 December 2017 2016 $ $
CASH FLOWS FROM OPERATING ACTIVITIES Receipts from customers 599,186 643,355
Payments to suppliers and employees (2,330,373) (1,988,253)
Interest received 14,964 4,766
Other income 548,212 551,263
Foreign exchange gains - 280
Finance costs (18,283) (35,176)
Net cash used in operating activities (1,186,294) (823,765)

CASH FLOWS FROM INVESTING ACTIVITIES
Payment for plant and equipment - (39,659)
Net cash used in investing activities - (39,659)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from share issued (net) 1,635,360 2,710,713
Net repayment of borrowings (93,750) (45,399)
Net cash provided by financing activities 1,541,610 2,665,314
Net movement in cash held 355,316 1,801,890
Cash at beginning of the financial period 2,590,330 881,823
Cash at end of the financial period $2,945,646 $2,683,713

Let the announcements roll on out.

What is missing?

As always,

Best

MM